Search Results 841-850 of 16792 for CLL

  1. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

    This research trial studies genetic profiles in blood and tumor samples from patients with estrogen receptor positive and HER2 negative breast cancer that has ...

  2. Stem cells: What they are and what they do - Mayo Clinic

    Chemotherapy side effects: A cause of heart disease? Chronic granulomatous disease · Chronic lymphocytic leukemia · Chronic myelogenous leukemia · Curcumin: Can ...

  3. Hematology - Clinical trials

    This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...

  4. Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) - Mayo Clinic

    Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) · Overview.

  5. Clinical trials - Oncology (Medical)

    Jacksonville, Fla. The purpose of this study is to evaluate the safety and feasibility of the spinal array in treatment of patients with leptomeningeal ...

  6. Neurosurgery - Clinical trials

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  7. A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

    About this study. Phase I Dose Escalation: Primary objective is to determine the MTD and the recommended dose for Phase I Extension.

  8. Oncology (Medical) - Doctors - Mayo Clinic

    ... Chronic lymphocytic leukemia, Waldenstrom macroglo...bulinemia, Monoclonal gammopathy of undetermined significance, Plasma cell disorders, AL amyloidosis.

  9. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...

  10. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ...